U.S. Household Products Stock News

NYSE:MBC
NYSE:MBCBuilding

MasterBrand (MBC) Is Down 12.9% After Q1 Loss And Lower Q2 Outlook Has The Bull Case Changed?

In the past quarter, MasterBrand, Inc. reported Q1 2026 sales of US$618 million, down from US$660.3 million a year earlier, and moved from a net income of US$13.3 million to a net loss of US$15.4 million. Alongside weaker results, the company guided to a further mid- to high-single-digit year-over-year sales decline for Q2 2026 and confirmed it repurchased 226,914 shares under its 2025 buyback plan while advancing cost cuts and tariff mitigation as it works toward a merger with American...
NasdaqGS:BRZE
NasdaqGS:BRZESoftware

Assessing Braze (BRZE) Valuation After CFO Departure And New CIO Appointment

Braze (BRZE) has announced a series of senior leadership moves, with Chief Financial Officer Isabelle Winkles set to leave after the current quarter, while Chief Accounting Officer Pankaj Malik steps in as interim CFO. See our latest analysis for Braze. At a share price of US$22.60, Braze has a 90 day share price return of 27.04%, set against a year to date share price decline of 30.57% and a 1 year total shareholder return decline of 32.86%. This suggests that recent momentum has picked up...
NYSE:BSX
NYSE:BSXMedical Equipment

Boston Scientific (BSX) Valuation Check After New Atrial Fibrillation And Stroke Prevention Data

Clinical data spotlight on cardiac technologies Boston Scientific (BSX) is back in focus after new clinical results for its FARAPULSE PFA and WATCHMAN LAAC platforms were presented at Heart Rhythm 2026, bringing real world atrial fibrillation and stroke risk reduction outcomes to investors. See our latest analysis for Boston Scientific. Despite the encouraging clinical headlines and corporate activity around governance changes, institutional ownership updates and a new US$565.7m shelf...
NYSE:DIS
NYSE:DISEntertainment

How Investors May Respond To Walt Disney (DIS) Q2 Results And Disney+ “Super App” Strategy

In early May 2026, The Walt Disney Company reported fiscal Q2 results showing revenue of US$25.17 billion, up from US$23.62 billion a year earlier, while net income declined to US$2.25 billion from US$3.28 billion and earnings per share also decreased, alongside confirmation of share repurchases totaling 112,376,398 shares for US$12.06 billion since February 2024. The earnings release doubled as new CEO Josh D’Amaro’s first major update, highlighting plans to make Disney+ the central hub...
NasdaqGS:CNXN
NasdaqGS:CNXNElectronic

Stronger Q1 Earnings And Steady Dividend Might Change The Case For Investing In PC Connection (CNXN)

PC Connection, Inc. reported past first-quarter 2026 results with sales of US$721.87 million and net income of US$17.22 million, alongside basic earnings per share of US$0.68 from continuing operations. On the same day, the company’s Board affirmed its capital return approach by declaring a US$0.20 per-share quarterly dividend, reinforcing the link between recent earnings strength and ongoing shareholder payouts. With this combination of stronger quarterly earnings and a maintained US$0.20...
NasdaqGS:EVCM
NasdaqGS:EVCMSoftware

Does EverCommerce’s AI Uptake And Profit Turnaround Reshape The Bull Case For EVCM?

EverCommerce Inc. reported past first-quarter 2026 results with revenue of US$147.47 million versus US$142.27 million a year earlier, and net income of US$7.17 million versus a net loss of US$7.71 million. The company highlighted growing uptake of its AI-enabled solutions and continued share repurchases, underscoring management’s focus on efficiency, higher-margin offerings, and capital returns. We’ll now examine how stronger profitability and accelerating adoption of AI-powered products...
NYSE:MDT
NYSE:MDTMedical Equipment

Should Medtronic’s (MDT) New Robotics and Neuromodulation Milestones Prompt a Fresh Look From Investors?

Recently, Medtronic announced several product milestones, including the first patient enrollment in its ENDURANCE Post-Approval Study for the Altaviva tibial neuromodulation device, the launch of its Adaptive Deep Brain Stimulation system for Parkinson’s disease in India, CE Mark clearance for the Stealth AXiS robotics and navigation platform in Europe, and FDA Breakthrough Device Designation for its Sphere-9 catheter. Together, these developments highlight Medtronic’s push into AI-enabled...
NYSE:PII
NYSE:PIILeisure

Polaris (PII) Valuation Check After A 98.47% One Year Total Return

Why Polaris is on investors’ radar now Polaris (PII) has drawn fresh attention after a year total return of 98.47% along with a recent month gain of 24.79%, prompting investors to reassess the stock’s valuation and risk profile. See our latest analysis for Polaris. With the share price at US$67.06, Polaris has seen a strong 30 day share price return of 24.79% and a 1 year total shareholder return of 98.47%. However, the 3 and 5 year total shareholder returns remain negative, which suggests...
NasdaqGS:TILE
NasdaqGS:TILECommercial Services

Does Interface’s Strong Q1 Beat and Higher 2026 Guidance Alter the Bull Case for TILE?

In early May 2026, Interface, Inc. reported Q1 2026 results that exceeded analyst expectations and raised its full-year 2026 net sales guidance to between US$1.45 billion and US$1.48 billion, while also forecasting Q2 2026 net sales of US$385 million to US$395 million. The company credited broad-based growth and margin improvement under its One Interface strategy, supported by strong demand across corporate office and healthcare markets and new products such as its Noravant rubber flooring...
NYSE:HAYW
NYSE:HAYWBuilding

A Look At Hayward Holdings (HAYW) Valuation After Raised Guidance And Strong First Quarter Results

Hayward Holdings (HAYW) drew fresh attention after reporting first quarter results, with sales of US$255.22 million and net income of US$23.36 million, alongside higher full year 2026 sales and earnings guidance. See our latest analysis for Hayward Holdings. Despite the stronger first quarter and higher 2026 guidance, Hayward Holdings’ 1-day and 7-day share price returns of 1.01% and 1.60% contrast with a 9.08% 1-month gain, while 1-year and 3-year total shareholder returns of 5.12% and...
NYSE:YETI
NYSE:YETILeisure

Yeti Holdings (YETI) Valuation Check After Fourth Quarter Earnings Beat And Strong International Growth

YETI Holdings (YETI) is back in focus after fourth quarter results topped revenue and earnings expectations, as drinkware and international sales caught investors’ attention ahead of the first quarter fiscal 2026 report. See our latest analysis for YETI Holdings. YETI Holdings’ recent fourth quarter beat and mixed analyst reactions have played out against a choppy share price pattern, with a 14.92% 1 month share price return and a 40.76% 1 year total shareholder return, in contrast with...
NasdaqGS:COCO
NasdaqGS:COCOBeverage

Assessing Vita Coco (COCO) Valuation After A Strong Multi‑Month Share Price Run

Recent performance snapshot for Vita Coco Company (COCO) With no single headline event driving attention to Vita Coco Company (COCO), recent performance is drawing interest. The stock shows a 0.6% decline over the past day but a 3.4% gain over the past week. Investors are also watching its longer streak, with the share price showing a roughly 39% move over the past month and about 16% over the past 3 months, set against year to date and 1 year total returns. See our latest analysis for Vita...
NasdaqGS:CTAS
NasdaqGS:CTASCommercial Services

Is It Time To Reassess Cintas (CTAS) After Its Recent Share Price Decline

If you are wondering whether Cintas is attractively priced or trading on too rich a premium, starting with a clear look at its current valuation can help you frame that decision. The stock last closed at US$170.04, with returns of a 2.7% decline over 7 days, a 0.1% decline over 30 days, an 8.0% decline year to date, a 20.2% decline over 1 year, 47.2% over 3 years and 101.2% over 5 years, which may shape how you think about both risk and opportunity. Recent news around Cintas has focused on...
NYSE:CPA
NYSE:CPAAirlines

A Look At Copa Holdings (NYSE:CPA) Valuation As Analyst Optimism Builds Ahead Of Upcoming Earnings

Recent analyst commentary around Copa Holdings (CPA) has focused on expectations for higher revenues and a possible earnings beat in the March 2026 quarter, with the upcoming May 13 report drawing closer attention. See our latest analysis for Copa Holdings. Copa Holdings' share price has recently picked up, with a 7 day share price return of 6.24% and a 30 day share price return of 10.16%. This comes even though the 90 day share price return is a 20.24% decline, while the 1 year total...
NYSE:AMN
NYSE:AMNHealthcare

AMN Healthcare Services (AMN) Is Up 9.7% After Mixed Q1 Beat, Soft Q2 Outlook And Governance Votes

In early May 2026, AMN Healthcare Services, Inc. reported first-quarter results showing US$1,378.36 million in sales and US$62.17 million in net income, followed by guidance for second-quarter revenue of US$620 million to US$635 million with an operating margin between 0.6% loss and 0.1% profit. Alongside these results, shareholders rejected a proposal for an independent board chair and the company filed a roughly US$29.99 million employee stock offering shelf registration, highlighting...
NYSE:ARE
NYSE:AREHealth Care REITs

A Look At Alexandria Real Estate Equities (ARE) Valuation After Dividend Cut And Softer Recovery Outlook

Alexandria Real Estate Equities (ARE) has drawn fresh attention after cutting its dividend by 45%, returning to profitability in the first quarter while reporting lower revenue and facing more cautious analyst commentary on its recovery. See our latest analysis for Alexandria Real Estate Equities. The share price recently bounced, with a 7 day share price return of 12.52%. However, the 90 day share price return shows an 18.46% decline and the 1 year total shareholder return shows a 34.04%...
NasdaqGS:IMKT.A
NasdaqGS:IMKT.AConsumer Retailing

Ingles Markets (IMKT.A) Is Down 6.2% After Earnings Beat And Activist Wins Board Seat - Has The Bull Case Changed?

Ingles Markets, Incorporated recently reported past second-quarter 2026 results showing sales of US$1,307.86 million and net income of US$24.27 million, alongside stronger first-half earnings versus the prior year. These financial results arrived just after activist investor Summer Road LLC secured board representation through the election of its nominee Rory A. Held, sharpening attention on Ingles’ governance and use of its real estate assets. We will now examine how the combination of...
NasdaqGM:ALNT
NasdaqGM:ALNTElectrical

Allient (ALNT) Is Down 13.6% After Q1 Margin Miss Amid Growing Sales And Dividend Declaration – Has The Bull Case Changed?

In early May 2026, Allient Inc. reported first-quarter 2026 results showing sales of US$138.92 million and net income of US$5.36 million, alongside a quarterly dividend of US$0.04 per share payable on June 4, 2026. Despite year-over-year growth in revenue and earnings per share, Allient’s first-quarter adjusted profit margins fell short of analyst expectations, highlighting tension between top-line momentum and cost pressures. With earnings growing but margins missing consensus, we’ll now...
NYSE:GRND
NYSE:GRNDInteractive Media and Services

Assessing Grindr (GRND) Valuation After Earnings Beat And Raised Revenue Guidance

Earnings surprise and guidance shift focus to Grindr’s growth plans Grindr (GRND) is in focus after first quarter 2026 results topped consensus expectations, along with higher full year revenue guidance and fresh detail on the upcoming premium Edge tier and expanding advertising efforts. See our latest analysis for Grindr. At a share price of $13.81, Grindr has seen a 35.0% 90 day share price return and a 12.37% 30 day share price return, although the 1 year total shareholder return of 43.52%...
NYSE:ANF
NYSE:ANFSpecialty Retail

A Look At Abercrombie & Fitch (ANF) Valuation After Barclays Downgrade And Recent Share Price Pullback

Barclays’ downgrade of Abercrombie & Fitch (ANF) to an Underweight rating, tied to rising competition, heavier promotions at Hollister, and expectations of margin normalization, has put fresh attention on what investors are currently paying for the stock. See our latest analysis for Abercrombie & Fitch. Those concerns have come after a sharp pullback, with the share price down 19.9% over the past month and 36.6% year to date, even though 1 year total shareholder return is 7.1% and 3 year...
NYSE:TREX
NYSE:TREXBuilding

Assessing Trex Company (TREX) Valuation As Shares Struggle With Recent Performance Shifts

Trex Company (TREX) is back in focus after recent share price moves, with the stock closing at US$39.19. Investors are weighing this level against the company’s earnings profile and current valuation signals. See our latest analysis for Trex Company. Recent trading has been choppy, with a 10.55% 1 month share price return contrasting with a 10.93% 3 month share price decline and a 32.78% 1 year total shareholder return loss. This suggests momentum has been fading even as investors reassess...
NasdaqGS:TARS
NasdaqGS:TARSPharmaceuticals

Assessing Tarsus Pharmaceuticals (TARS) Valuation After Recent Share Price Weakness And Pipeline Growth Expectations

Event context and recent stock performance Tarsus Pharmaceuticals (TARS) has attracted investor attention recently as its share price has moved over the past month and past 3 months, with the stock last closing at US$63.96 and a market value of about US$2.8b. See our latest analysis for Tarsus Pharmaceuticals. Zooming out, the stock’s recent share price returns, including a 6.98% 1 month decline and a 20.81% year to date decline, contrast with a 35.68% 1 year total shareholder return and very...
NYSE:ENOV
NYSE:ENOVMedical Equipment

Enovis (ENOV) Is Up 16.3% After Reaffirming 2026 Outlook And Narrowing Losses – Has The Bull Case Changed?

Enovis Corporation recently reported first-quarter 2026 results, with sales rising to US$589.15 million from US$558.83 million a year earlier and net loss narrowing to US$8.76 million from US$55.97 million, while basic and diluted loss per share from continuing operations improved to US$0.15 from US$0.98. The company also reaffirmed its full-year 2026 revenue guidance of about US$2.31 billion to US$2.37 billion, highlighting confidence in growth from its Reconstructive segment and new...
NasdaqGS:XMTR
NasdaqGS:XMTRTrade Distributors

Xometry (XMTR) Is Up 53.1% After Siemens Invests $50M And Deepens AI Integration

Xometry, Inc. reported Q1 2026 revenue of US$205.14 million, up from US$150.97 million a year earlier, while its net loss narrowed to US$5.27 million and basic loss per share improved to US$0.10. In parallel, Siemens agreed to invest about US$50,000,000 in Xometry and embed Xometry’s AI-powered manufacturing intelligence directly into the Siemens Xcelerator software suite, deepening Xometry’s integration into customers’ design and sourcing workflows. Next, we’ll examine how Siemens’...